Mexiletine dosing and tolerability in refractory chronic migraine: Insights from post-lidocaine infusion treatment
Background Mexiletine is used as a preventive medication for refractory chronic migraine (rCM) and to prolong migraine improvement following intravenous lidocaine infusion. However, published evidence supporting its use in migraine remains limited. This retrospective study describes the dosing, trea...
Saved in:
Main Authors: | Lucia Liao, Hsiangkuo Yuan, Dylan Selbst, Emily Casaletto, Jiangang Liao, Clinton G. Lauritsen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Cephalalgia Reports |
Online Access: | https://doi.org/10.1177/25158163241313123 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcervical Intrauterine Levobupivacaine or Lidocaine Infusion for Pain Control during Endometrial Biopsy
by: Nermin Kosus, et al.
Published: (2014-01-01) -
Review of Interventional Therapies for Refractory Pediatric Migraine
by: Jacquelin Peck, et al.
Published: (2023-01-01) -
Lidocaine Infusion for the Management of Postoperative Pain and Delirium (LIMPP): protocol for a randomised control trial
by: Matthias Behrends, et al.
Published: (2022-06-01) -
Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review
by: Sumit Sohal, et al.
Published: (2021-01-01) -
The Effects of Preoperative Oral Pregabalin and Perioperative Intravenous Lidocaine Infusion on Postoperative Morphine Requirement in Patients Undergoing Laparatomy
by: Senniye Ulgen Zengin, et al.
Published: (2015-01-01)